A review of clinical profile in sickle cell traits

Oman Medical Journal

Volumn 25, Issue 1, 2010, Pages 3-8

  John, Nitin ^a  

^a NKP SALVE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A; HEMOGLOBIN S;

ABDOMINAL PAIN; ACIDOSIS; BACTERIURIA; BLOOD VESSEL OCCLUSION; END STAGE RENAL DISEASE; ERYTHROCYTE; EXERCISE; GENETIC VARIABILITY; GLAUCOMA; HEALTH STATUS; HEMATURIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERNATREMIA; HYPEROSMOLALITY; HYPERTHERMIA; HYPHEMA; HYPOTHERMIA; HYPOXIA; INFLAMMATION; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LEUKOCYTOSIS; MORBIDITY; MORTALITY; POLYMERIZATION; PYELONEPHRITIS; RENAL MEDULLARY CARCINOMA; REVIEW; SICKLE CELL TRAIT; SPLEEN INFARCTION; THORAX SURGERY; URINARY TRACT INFECTION; URINE OSMOLALITY;

EID: 84900448631     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2010.2     Document Type: Review

References (29)

1. Jyoti T, Suresh C, Madhur G, Nitin PJ. Pro-Oxidant and Anti-oxidant status in patients of sickle cell anaemia. Indian J Clin Biochem 2004;19(2):168-172.
2. Jyoti T, Madhur G, Nitin PJ, Chari SN. Role of serum uric acid as an antioxidant in sickle cell anaemia. Ind Med Gaz 2005;3:97-99.
3. Sears DA. The morbidity of sickle cell trait: a review of the literature. Am J Med 1978 Jun;64(6):1021-1036.
4. Serjeant GR. The sickle cell trait. In: Serjeant GR, ed., Sickle cell disease. New York City, Oxford University Press, 1992: 415-425.
5. Kark JA, Ward FT. Exercise and hemoglobin S. Semin Hematol 1994 Jul;31(3):181-225.
6. Eichner ER. Sickle cell trait. J Sport Rehabil 2007 Aug;16(3):197-203.
7. Gupta AK, Kirchner KA, Nicholson R, Adams JG III, Schechter AN, Noguchi CT, et al. Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait. J Clin Invest 1991 Dec;88(6):1963-1968.
8. Statius Van Eps LW, De Jong PE. Sickle Cell Disease., In: Schrier RW, Gottschalk, CW, eds. Disease of the Kidney, 1997; p. 2201-2219.
9. López de Guimaraes D, Menacho López J, Villanueva Palacios J, Mosquera Vásquez V. [Splenic infarction at high altitude, Huaraz-Peru (3,100 masl)]. Rev Gastroenterol Peru 2009 Apr-Jun;29(2):179-184.
10. Jones SR, Binder RA, Donowho EM Jr. Sudden death in sickle-cell trait. N Engl J Med 1970 Feb;282(6):323-325.
11. Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 1979 May;300(18):1001-1005.
12. Bencaiova G, Krafft A, Breymann Ch. Sickle cell trait and urinary tract infection in pregnancy. Int J Gynaecol Obstet 2006 Feb;92(2):128-129.
13. Yium J, Gabow P, Johnson A, Kimberling W, Martinez-Maldonado M. Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin. J Am Soc Nephrol 1994 Mar;4(9):1670-1674.
14. Srigley JR, Delahunt B. Uncomman and recent described renal carcinomas. Mod Pathol 2009 Jun;2(2):2-23.
15. Avery RA, Harris JE, Davis CJ Jr, Borgaonkar DS, Byrd JC, Weiss RB. Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer 1996 Jul;78(1):128-132.
16. Leitão VA, da Silva W Jr, Ferreira U, Denardi F, Billis A, Rodrigues Netto N Jr. Renal medullary carcinoma. Case report and review of the literature. Urol Int 2006;77(2):184-186.
17. Scott-Connor CE, Brunson CD. Surgery and anesthesia. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease: basic principles and clinical practice. New York, Raven Press, 1994: 809-27.
18. Atlas SA. The sickle cell trait and surgical complications. A matched-pair patient analysis. JAMA 1974 Aug;229(8):1078-1080.
19. Métras D, Coulibaly AO, Ouattara K, Longechaud A, Millet P, Chauvet J. Open-heart surgery in sickle-cell haemoglobinopathies: report of 15 cases. Thorax 1982 Jul;37(7):486-491.
20. Castro O, Rana S. Approach to patients with special red blood cell disorders: sickle hemoglobinopathies, polycythemia, and autoimmune hemolytic anemias. In: Spiess, B, ed. Perioperative Transfusion Medicine. Baltimore, Williams & Wilkins, 1998: 231-232.
21. Acharya K, Lang CW, Ross LF. A pilot study to explore knowledge, attitudes, and beliefs about sickle cell trait and disease. J Natl Med Assoc 2009 Nov;101(11):1163-1172.
22. Cohen-Solal M, Préhu C, Wajcman H, Poyart C, Bardakdjian-Michau J, Kister J, et al. A new sickle cell disease phenotype associating Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an alpha2 globin gene variant (Hb Conakry). Br J Haematol 1998 Dec;103(4):950-956.
23. Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med 2009 Jun;122(6):507-512.
24. Monplaisir N, Merault G, Poyart C, Rhoda MD, Craescu C, Vidaud M, et al. Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci U S A 1986 Dec;83(24):9363-9367.
25. Creary M, Williamson D, Kulkarni RJ. Sickle cell disease: current activities, public health implications, and future directions. J Womens Health (Larchmt) 2007 Jun;16(5):575-582. Review.
26. Treadwell MJ, McClough L, Vichinsky E. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc 2006 May;98(5):704-710.
27. Pack-Mabien A, Haynes J Jr. A primary care provider’s guide to preventive and acute care management of adults and children with sickle cell disease. J Am Acad Nurse Pract 2009 May;21(5):250-257. Review.
28. Kavanagh PL, Wang CJ, Therrell BL, Sprinz PG, Bauchner H. Communication of positive newborn screening results for sickle cell disease and sickle celltrait: variation across the state. Am J Med Genet C Semin Med Genet 2008 Feb;15(1):15-22.
29. Lerner NB, Platania BL, LaBella S. Newborn sickle cell screening in a region of Western New York State. J Pediatr 2009 Jan;154(1):121-125.